| 000 | 01843 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250515005700.0 | ||
| 264 | 0 | _c20060127 | |
| 008 | 200601s 0 0 hun d | ||
| 022 | _a0030-6002 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTamási, Lilla | |
| 245 | 0 | 0 |
_a[The management of bronchial asthma during pregnancy--Hungarian experiences]. _h[electronic resource] |
| 260 |
_bOrvosi hetilap _cNov 2005 |
||
| 300 |
_a2305-9 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlbuterol _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAnti-Asthmatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAsthma _xcomplications |
| 650 | 0 | 4 | _aBirth Weight |
| 650 | 0 | 4 |
_aBudesonide _xtherapeutic use |
| 650 | 0 | 4 | _aCesarean Section |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xetiology |
| 650 | 0 | 4 |
_aEthanolamines _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aForced Expiratory Flow Rates _xdrug effects |
| 650 | 0 | 4 | _aFormoterol Fumarate |
| 650 | 0 | 4 | _aGuideline Adherence |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHungary _xepidemiology |
| 650 | 0 | 4 |
_aOxygen _xblood |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aPre-Eclampsia _xetiology |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications _xdrug therapy |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSalmeterol Xinafoate |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSocieties, Medical |
| 650 | 0 | 4 |
_aTerbutaline _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aBohács, Anikó | |
| 700 | 1 | _aPállinger, Eva | |
| 700 | 1 | _aRigó, János | |
| 700 | 1 | _aMagyar, Pál | |
| 700 | 1 | _aLosonczy, György | |
| 773 | 0 |
_tOrvosi hetilap _gvol. 146 _gno. 45 _gp. 2305-9 |
|
| 999 |
_c15928140 _d15928140 |
||